Charlie Ahn

Dr. Charlie Ahn is a Research Fellow at the Macquarie Medical School, Macquarie University. His research focuses on proteomics, cancer biomarker discovery, and molecular mechanisms of colorectal and breast cancers. He leads and collaborates on projects such as 'Protein Biosignatures for Predicting Colorectal Cancer Recurrence' and 'uPAR Peptide Therapeutics for Cancer Metastasis'.

• Active projects: Biomolecular Discovery and Design Research Centre (2017–), Next Generation Colorectal Cancer Biomarkers (2016–)
• Research interests: Proteomic analysis of cancer progression, extracellular vesicles, and kynurenine pathway proteins

His work employs advanced mass spectrometry and spectral library techniques, contributing to over 45 peer-reviewed publications. Key collaborations include work on microglial cell lines and metastasis-associated enzymes.

Notable contributions include identifying HEXB-driven glycoproteomic changes in colorectal cancer and developing methods for low-abundance protein quantification.